Compare Hedera (HBAR) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hedera vs Injective — how do they compare? Hedera trades at Rp1,210 (market cap Rp52,99T, Rp825,41M 24h volume), while Injective trades at Rp93,049 (market cap Rp9,21T, Rp1,85T 24h volume). The key difference: Hedera is far larger — about 5.8× Injective's market cap, and Hedera's supply is capped (43,8B / 50B HBAR (88%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Hedera for 55 Days and Injective for 36 Days on average.
| HBAR | INJ | |
|---|---|---|
Market Cap | Rp52,99T | Rp9,21T |
Volume (24h) | Rp825,41M | Rp1,85T |
Circulating Supply | 43,8B / 50B HBAR (88%) | 100M INJ |
Typical Hold Time | 55 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hedera (HBAR) is currently trading at Rp1,218.08 with a market cap of Rp53.17 trillion, exhibiting a bearish technical signal driven by moving averages. The token is near its pivot point of Rp1,211, with support at Rp1,194 and resistance at Rp1,235. Circulating supply is 43.8M out of 50M HBAR, with an 88% circulation rate. No major protocol updates or ecosystem news are noted recently.
Overall outlook is cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebounds from oversold RSI levels, while risks involve high volatility and regulatory uncertainties. Investors should monitor support levels and on-chain activity for signs of reversal.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hedera
Hedera (HBAR) is the most used, sustainable, enterprise-grade public network for the decentralized economy that allows individuals and businesses to create powerful decentralized applications (DApps). Hedera Hashgraph isn’t built on top of a conventional blockchain. Instead, it introduces a completely novel type of distributed ledger technology known as a Hashgraph. This technology allows it to improve upon many blockchain-based alternatives in several key areas, including speed, cost, and scalability.
Read more on HBAR →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
